Home - Products - Cell Cycle/DNA Damage - DNA/RNA Synthesis - Methylbenactyzine Bromide

Methylbenactyzine Bromide

CAS No. 3166-62-9

Methylbenactyzine Bromide( —— )

Catalog No. M18416 CAS No. 3166-62-9

Dimethadione is an anticonvulsant that is the active metabolite of trimethadione.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	28	In Stock
100MG	37	In Stock
200MG	Get Quote	In Stock
500MG	99	In Stock
1G	144	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Methylbenactyzine Bromide
Note

Research use only, not for human use.
Brief Description

Dimethadione is an anticonvulsant that is the active metabolite of trimethadione.
Description

Dimethadione is an anticonvulsant that is the active metabolite of trimethadione.(In Vitro):Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor. Methylbenactyzium bromide has been used as a spasmolytic for the treatment of gastrointestinal ulcer.
In Vitro

Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor. Methylbenactyzium bromide has been used as a spasmolytic for the treatment of gastrointestinal ulcer.
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

DNA/RNA Synthesis
Recptor

mAChR
Research Area

Neurological Disease
Indication

——

Chemical Information

CAS Number

3166-62-9
Formula Weight

422.36
Molecular Formula

C21H28BrNO3
Purity

>98% (HPLC)
Solubility

DMSO : 6 mg/mL 14.21 mM
SMILES

O=C(OCC[N+](CC)(CC)C)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[Br-]
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Bhattacharjee AK,etal.Bioorg Med Chem. 2013 May 1;21(9):2651-62.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Sorivudine

Sorivudine has antiviral activity against several viruses including varicella zoster virus, herpes simplex type 1 virus, and Epstein-Barr virus by interfering with viral DNA synthesis.
JH-RE-06

JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.
Ddr1-In-1

DDR1-IN-1 is an effective and specific?DDR1?receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.

Sign In Join Free